|
MedMen is a management and consulting firm for the medical marijuana industry based in Los Angeles, CA. The company was co-founded by Adam Bierman and Andrew Modlin in 2010. They have affiliates or branches in Arizona, Illinois, Nevada and Massachusetts.〔 Since its inception, MedMen has helped more than 100 businesses in the U.S. navigate the complexities of entering and succeeding in the legal marijuana market, from effectively completing state applications to managing the day-to-day operations of a mature business. In 2014, it secured $3.75 million in financing to launch operations in Nevada and Illinois, funding which represented the largest capital investment at the time in a full-service cannabis management firm. In February 2015, MedMen obtained the state and local permits required to open a medical marijuana cultivation facility in Henderson, Nevada, marking the first full suite of licenses in that state for the company. MedMen brings together expertise in three critical areas—licensing, design and management—to help businesses maximize their space and brand identity, and grow a legitimate and stable operation. The objective of the firm is to help ensure each business is following the proper legal and compliance procedures, but also meeting its potential in the areas of raising capital and securing financing, as well as with real estate, interior design, construction, security, staffing, marketing, graphic design, website design, and maintenance. ==Partnership With MedReleaf== MedMen's partnership with MedReleaf will bring MedMen to Canada to help further optimize MedReleaf's operations with a specific focus on infused and extract product lines. Reciprocally, MedReleaf will be expanding into the U.S. where MedMen will manufacture and distribute MedReleaf's premium products. MedMen brings its operational expertise in cannabis cultivation and extraction to further enhance MedReleaf's operations. MedReleaf services thousands of patients daily, a number that is only increasing as the industry continues to open up. MedMen will consult on extraction methodologies, manufacturing methodologies, cultivation methodologies, product development, packaging and marketing, and SOPs. In addition to consulting services, MedMen will provide MedReleaf with a license to use MedMen's proprietary tracking software. The software program is a seed‑to‑ship physical tracking system that constantly checks the vital signs of a macro‑sized grow operation. It collects operation improvement data, provides long‑term forecasting, resource planning, purchasing assistance, and full recall trace protection. The program handles cultivation, extraction, and production. As part of the new agreement, MedMen will produce MedReleaf's first-rate products to be sold in the US under MedMen's client-operated facilities and the two leading organizations will seek to collaborate in other jurisdictions and markets. Also, MedReleaf CEO Neil Closner will join MedMen's Board of Advisors effective immediately. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「MedMen」の詳細全文を読む スポンサード リンク
|